141 / 1631
JD Brody,
J Clin Oncol 2010;28(28):4324-4332
In situ vaccination with a TLR9 agonist
induces systemic lymphoma response
•
15 patients with r/r iNHL
•
CpG + low-dose RT single site of disease
•
Response assessment at distant sites
•
Treatment induced CD8+ memory T cells and Treg expansion in some patients
•
Best response in Tregs non inducers